Prestige Consumer Healthcare
PBH
£55.90
Share price
-2.16%
Change (1 day)
1.88%
Change (1 year)
Categories
Market capitalization of Prestige Consumer Healthcare (PBH)
Market cap: £2.75 Billion
As of July 2025 Prestige Consumer Healthcare has a market cap of £2.75 Billion. This makes Prestige Consumer Healthcare the world's 3511th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Prestige Consumer Healthcare from 2005 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | £2.75 B | -10.89% |
| 2024 | £3.08 B | 29.54% |
| 2023 | £2.38 B | -6.96% |
| 2022 | £2.56 B | 13.83% |
| 2021 | £2.25 B | 75.64% |
| 2020 | £1.28 B | -17.42% |
| 2019 | £1.55 B | 23.17% |
| 2018 | £1.26 B | -27.7% |
| 2017 | £1.74 B | -22.02% |
| 2016 | £2.23 B | 21.96% |
| 2015 | £1.83 B | 57.26% |
| 2014 | £1.16 B | 3.72% |
| 2013 | £1.12 B | 77.7% |
| 2012 | £0.63 B | 72.9% |
| 2011 | £0.36 B | -5.67% |
| 2010 | £0.38 B | 59.53% |
| 2009 | £0.24 B | -32.56% |
| 2008 | £0.36 B | 91.4% |
| 2007 | £0.18 B | -43.36% |
| 2006 | £0.33 B | -8.39% |
| 2005 | £0.36 B |
End of Day market cap according to different sources
On Jul 29th, 2025 the market cap of Prestige Consumer Healthcare was reported to be:
£2.76 Billion
£2.75 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 GlaxoSmithKline GSK | £57.19 B | 1,978.33% | 🇬🇧 UK |
 Pfizer PFE | £103.45 B | 3,659.03% | 🇺🇸 USA |
 Rite Aid
RAD | £27.52 M | -99.00% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £303.16 B | 10,915.94% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | £1.20 B | -56.06% | 🇮🇱 Israel |
 Novartis NVS | £171.61 B | 6,135.70% | 🇨🇭 Switzerland |
 Procter & Gamble PG | £274.94 B | 9,890.51% | 🇺🇸 USA |
 CVS Health CVS | £56.83 B | 1,965.19% | 🇺🇸 USA |
 Clorox CLX | £11.72 B | 326.04% | 🇺🇸 USA |
 Abbott Laboratories ABT | £166.77 B | 5,959.87% | 🇺🇸 USA |